Search Header Logo

COZAAR Label update October 2022

Authored by Nthabiseng Mashaphu

Professional Development

3rd Grade

Used 2+ times

COZAAR Label update October 2022
AI

AI Actions

Add similar questions

Adjust reading levels

Convert to real-world scenario

Translate activity

More...

    Content View

    Student View

8 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

COZAAR is now packed in a pack of 25s, 50s and 100

TRUE

FALSE

2.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

What is the recommended dose in patients 6-16 years of age, weighing 20 or less than 50 kg

50 mg once daily

100 mg once daily

25 mg once daily

3.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

What is the recommended dose in patients 6-16 years of age, weighing more than or equals to 50 kg

50 mg once a day

25 mg once a day

100 mg once a day

4.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

The safety and efficacy use in of children has not been established from what age in paediatric population?

6 months-2 years

2-6 years

6 months-less than 6 years

6 years and younger

5.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

Concomitant use of fluoroquinolones with ACE inhibitors/Renin-Angiotensin is contraindicated in which patients?

Only moderate renal impairment

Only severe renal impairment

Mild to noderate renal impairment

Moderate to severe renal impairment

6.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

COZAAR is safe for administration with aliskerin in patients with diabetes?

FALSE

TRUE

7.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

Administration of aliskerin with COZAAR in patients with diabetes should be given with caution?

TRUE

FALSE

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?